[8] HayID, HutchinsonME, Gonzalez-LosadaT, : astudyof900casesobservedina60-yearperiod [J].Surgery,2008, 144（6）:980-987.
[9] 关海霞．甲状腺微小**状癌的观察——慎思之，明辨之，笃行之[J]．中华内分泌代谢杂志，2017, 33（4）:92-95.
[10] HaugenBRMd, AlexanderEK, BibleKC, etal.2015AmericanThyroidAssociationManagementGuidelinesforAdultPatientswithThyroidNodulesandDifferentiatedThyroidCancer [J].Thyroid,2015, Oct14.[Epubaheadofprint].
[11] AmericanThyroidAssociation （ATA）guidelinestaskforceonthyroidnodulesanddifferentiatedthyroidcancer, CooperDS, DohertyGM, [J].Thyroid, 2009, 19（11）:1167-1214.
[12] 中华医学会内分泌学分会，中华医学会外科学分会内分泌学组，中国抗癌协会头颈肿瘤专业委员会，等．甲状腺结节和分化型甲状腺癌诊治指南[J]．中华内分泌代谢杂志，2012, 28（10）: :10.3760/.1000-6699.2012.10.002.
[13] LamartinaL, DuranteC, FilettiS, -riskdifferentiatedthyroidcancerandradioiodineremnantablation: asystematicreviewoftheliterature [J].JClinEndocrinolMetab, 2015, 100（5）:1748-1761.
[14] McLeodDS, SawkaAM, -riskpapillarythyroidcancer [J].Lancet,2013, 381（9871）:1046-1057.
[15] 关海霞．甲状腺微小癌术后促甲状腺激素抑制治疗：认识和挑战[J]．中国实用外科杂志，2016, 36 （5）:524-527.
[16] AmitM, RudnickiY, BinenbaumY, [J].Laryngoscope, 2014, 124（12）: : 10.1002/lary.24744.
[17] [J].WorldJSurg, 2016, 40: : 10.1007/s00268-015-3392-y.
[18] SugitaniI, TodaK, YamadaK, : ourtreatmentstrategiesandoutcomes [J].WorldJSurg, 2010, 34（6）: : 10.1007/s00268-009-0359-x.
[19] .Oralpresentationatthe87thATAannualmeeting [J].Thyroid, 2016, 26（S1）:: 10.1089/.
[20] YoshidaA, [M].Tokyo: KaneharaShuppan, 2010.
[21] 中国抗癌协会甲状腺癌专业委员会（CATO）．甲状腺微小**状癌诊断与治疗中国专家共识（2016版）[J]．中国肿瘤临床，2016, 43（10）: : 10.3969/.1000- 8179.2016.10.001.
[22] TufanoRP, NoureldineSI, : considerationsbeforedeterminingmanagement [J].JAMAOtolaryngolHeadNeckSurg, 2015, 141（6）: : 10.1001/jamaoto.2015.0647.
[23] HaserGC, TuttleRM, SuHK, : newchallengesandopportunitiesforthehealthcaresystem [J].EndocrPract, 2016, 22（5）: : 10.4158/EP151065.
哦豁，小伙伴们如果觉得倾城文选不错，记得收藏网址 或推荐给朋友哦~拜托啦 (>.<)
传送门：